If you have non-small cell lung cancer, you may benefit from treatment with Navelbine. This prescription medication is given as an injection into a vein once a week. It works by preventing the growth and multiplication of cancer cells, causing them to die. Side effects include nausea, loss of strength, and a decrease in white blood cells.
Navelbine contains the active ingredient vinorelbine tartrate, or simply vinorelbine. This drug belongs to a general class of chemotherapy medicines called plant alkaloids. There are several types of plant alkaloids, and Navelbine is a vinca alkaloid. Vinca alkaloids are anticancer medicines derived from the Madagascar periwinkle plant (Catharanthus roseus).
Navelbine is made by Pierre Fabre Médicament for Pierre Fabre Pharmaceuticals, Inc.
How Does Navelbine Work?
Navelbine belongs to a group of chemotherapy medications called vinca alkaloids. Vinca alkaloids are also called antimicrotubule agents. This is because they work by preventing the formation of structures inside cells known as microtubules. Microtubules play an important part in helping cells divide and multiply.
By preventing the formation of microtubules, antimicrotubule agents, such as Navelbine, stop cells from growing and dividing, which causes the cells to die.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Navelbine [package insert]. Parsippany, NJ: Pierre Fabre Pharmaceuticals, Inc.;2007 October.
Chabner BA, Bertino J, Cleary J, et al. Chapter 61. Cytotoxic Agents. In: Chabner BA, Brunton LL, Knollman BC, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 12nd ed. New York: McGraw-Hill; 2011. http://www.accesspharmacy.com.offcampus.lib.washington.edu/content.aspx?aID=16680251. Accessed September 24, 2012.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed September 24, 2012.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed September 24, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click